$KYNB 8-K SEC Filings

Filed On	Filing
06 Oct 2026	8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing On September 30, 2026, Kyntra Bio, Inc. (the “Company” or “Kyntra Bio”) received a determination letter (“Determination”) from the Listing Qualifications Staff (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company...
01 Oct 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers SAN FRANCISCO, October 1, 2026 (GLOBE NEWSWIRE) -- Kyntra Bio (Nasdaq: KYNB) today announced the appointment of Andrew E. Singer, MBA to its Board of Directors as an independent director and member of the Audit Committee effective Octobe...
31 Aug 2026	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more
13 Aug 2026	8-K: Results of Operations and Financial Condition
16 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
09 Jun 2026	8-K: Other Events
11 May 2026	8-K: Results of Operations and Financial Condition
09 Apr 2026	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
16 Mar 2026	8-K: Results of Operations and Financial Condition
07 Jan 2026	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year; Other Events
10 Nov 2025	8-K: Results of Operations and Financial Condition
06 Nov 2025	8-K: Other Events
05 Sep 2025	8-K: Completion of Acquisition or Disposition of Assets
02 Sep 2025	8-K: Other Events
18 Aug 2025	8-K: Other Events
14 Aug 2025	8-K: Entry into a Material Definitive Agreement
11 Aug 2025	8-K: Results of Operations and Financial Condition
14 Jul 2025	8-K: Entry into a Material Definitive Agreement
13 Jun 2025	8-K: Termination of a Material Definitive Agreement
12 Jun 2025	8-K: Material Modification to Rights of Security Holders; Amendments to Articles/Bylaws; Change in Fiscal Year

Comments